Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $565.69 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $162.95 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $117.18 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $81.48 | 1 | $0 (2022) |
| Boston Scientific Corporation | $75.14 | 1 | $0 (2019) |
| AbbVie Inc. | $46.72 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.62 | 2 | $0 (2021) |
| PFIZER INC. | $17.35 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $15.89 | 1 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $15.36 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $231.80 | 2 | Janssen Biotech, Inc. ($117.18) |
| 2022 | $129.81 | 2 | Regeneron Healthcare Solutions, Inc. ($81.48) |
| 2021 | $98.93 | 5 | AbbVie Inc. ($46.72) |
| 2020 | $15.36 | 1 | Intercept Pharmaceuticals, Inc. ($15.36) |
| 2019 | $89.79 | 2 | Boston Scientific Corporation ($75.14) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: Immunology | ||||||
| 02/28/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $114.62 | General |
| Category: CRITICAL CARE | ||||||
| 11/05/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $48.33 | General |
| Category: CRITICAL CARE | ||||||
| 08/18/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $81.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/16/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 01/28/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 11/13/2019 | Boston Scientific Corporation | GENERAL - POLYPECTOMY (Device) | Food and Beverage | In-kind items and services | $75.14 | General |
| Category: POLYPECTOMY | ||||||
| 01/23/2019 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 61 | 64 | $53,790 | $8,479 |
| 2022 | 4 | 81 | 81 | $95,025 | $11,254 |
| 2021 | 11 | 482 | 494 | $294,984 | $54,073 |
| 2020 | 7 | 172 | 175 | $86,971 | $20,274 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $29,000 | $4,455 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $3,740 | $1,637 | 43.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $18,080 | $1,247 | 6.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,970 | $1,141 | 38.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $46,400 | $6,845 | 14.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $28,250 | $1,795 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,410 | $1,574 | 46.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $16,965 | $1,041 | 6.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 52 | 52 | $58,643 | $11,109 | 18.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $38,065 | $7,669 | 20.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 88 | 89 | $44,375 | $7,106 | 16.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 53 | 54 | $27,069 | $5,975 | 22.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 50 | 50 | $38,451 | $5,501 | 14.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 51 | 52 | $20,880 | $4,314 | 20.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $17,348 | $3,289 | 19.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 21 | 21 | $17,505 | $3,214 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 49 | $16,928 | $3,019 | 17.8% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 17 | 17 | $8,777 | $1,604 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 14 | $6,943 | $1,273 | 18.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 22 | 22 | $21,978 | $4,962 | 22.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 28 | 28 | $12,236 | $3,335 | 27.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 35 | 35 | $12,215 | $3,035 | 24.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $10,051 | $2,655 | 26.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 27 | 28 | $11,660 | $2,520 | 21.6% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 20 | 20 | $13,472 | $2,248 | 16.7% |
About Dr. Rishabh Sachdev, M.D
Dr. Rishabh Sachdev, M.D is a Gastroenterology healthcare provider based in Farmington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1346650470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rishabh Sachdev, M.D has received a total of $565.69 in payments from pharmaceutical and medical device companies, with $231.80 received in 2023. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($565.69).
As a Medicare-enrolled provider, Sachdev has provided services to 796 Medicare beneficiaries, totaling 814 services with total Medicare billing of $94,080. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Farmington, CT
- Active Since 04/29/2014
- Last Updated 09/26/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346650470
Products in Payments
- TERLIVAZ (Drug) $162.95
- STELARA (Biological) $117.18
- DUPIXENT (Biological) $81.48
- GENERAL - POLYPECTOMY (Device) $75.14
- HUMIRA (Biological) $46.72
- ENTYVIO (Biological) $33.62
- ELIQUIS (Drug) $17.35
- OCALIVA (Drug) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Farmington
James Freston, M.d, M.D
Gastroenterology — Payments: $1.2M
Houman Rezaizadeh, M.d, M.D
Gastroenterology — Payments: $65,272
Dr. Neil Parikh, M.d, M.D
Gastroenterology — Payments: $39,683
Dr. John Birk, M.d, M.D
Gastroenterology — Payments: $13,329
George Wu, Md, MD
Gastroenterology — Payments: $11,476
Michelle Smedley, Md, MD
Gastroenterology — Payments: $9,046